RealShowcase
20.05.2010
Oncolytic viruses mediating anti-tumor immunity in human cancer patients published by Oncos Therapeutics and University of Helsinki
Oncos Therapeutics have publisheda report containing initial results from their Advanced Therapy Access Program in Cancer Research. The results demonstrate anti-tumor immunity of oncolytic viruses and indicate strong efficacy of the next generation viruses against solid tumor cancers. This research will appeal medical and bioscience professionals who are interested in the latest leading developments, like those who read PhysOrg.com. This leading US medical and scientific research website is a great platform for Oncos Therapeutics' research to be showcased to a relevant audience.Coverage
PhysOrg.comRealWire Influence RatingReadership: 1,500,000